Explore 3 Stock Ideas & Industry Insights Download Free Report

CYIOS Corporation

Healthcare US CYIO

0.0014USD
0.00(0%)

Last update at 2026-06-22T20:00:00Z

Day Range

0.00130.0014
LowHigh

52 Week Range

0.00080.0085
LowHigh

Fundamentals

  • Previous Close 0.0014
  • Market Cap0.65M
  • Volume21200
  • P/E Ratio-
  • Dividend Yield-%
  • Revenue TTM1.49M
  • Revenue Per Share TTM0.04
  • Gross Profit TTM 0.65M
  • Diluted EPS TTM-

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Income before tax -1.30700M -0.27400M -2.38400M -2.89000M -0.73700M
Minority interest - - - - -
Net income -1.30700M -0.36500M -2.38400M -2.89000M -0.73700M
Selling general administrative - - - - -
Selling and marketing expenses - - - - -
Gross profit 0.53M 0.04M 0.06M -0.03269M 0.01M
Reconciled depreciation - - - - -
Ebit - 0.13M -1.55000M -1.12163M -0.72300M
Ebitda -0.90800M 0.13M -1.32151M -1.12100M -0.51670M
Depreciation and amortization - 0.00187M 0.23M 0.00063M 0.21M
Non operating income net other - - - - -
Operating income -0.19300M -0.45600M -1.08200M -1.19700M -0.72300M
Other operating expenses 8.21M 0.49M 1.18M 1.94M 0.76M
Interest expense 0.40M 0.40M 0.83M 1.77M 0.01M
Tax provision - - - - -
Interest income - - - - -
Net interest income - - - - -
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense - -0.00001M -0.22800M 0.00001M -0.20600M
Total revenue 8.02M 0.04M 0.10M 0.74M 0.04M
Total operating expenses 0.73M 0.49M 1.14M 1.16M 0.74M
Cost of revenue 7.49M 0.00187M 0.04M 0.78M 0.03M
Total other income expense net -1.11500M 0.09M -1.30200M -1.69300M -0.01367M
Discontinued operations - - - - -
Net income from continuing ops - - - - -
Net income applicable to common shares - - - - -
Preferred stock and other adjustments - - - - -
Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Total assets 0.96M 1.02M 1.05M 1.57M 0.06M
Intangible assets - - - - -
Earning assets - - - - -
Other current assets 0.07M 0.03M 0.07M 0.11M -
Total liab 2.99M 2.53M 2.51M 1.68M 0.59M
Total stockholder equity -2.02612M -1.51374M -1.46388M -0.10745M -0.52938M
Deferred long term liab - - - - -
Other current liab -0.00000M 0.00000M 0.01M 0.01M -
Common stock 0.28M 0.24M 0.15M 0.12M 0.09M
Capital stock - - - - -
Retained earnings -32.44244M -31.22557M -30.86080M -28.47663M -25.60433M
Other liab - - - - -
Good will 0.25M 0.93M 0.93M 0.68M -
Other assets - 0.00000M - - -
Cash 0.03M 0.00666M 0.00011M 0.34M 0.04M
Cash and equivalents - - - - -
Total current liabilities 2.99M 2.53M 2.51M 1.68M 0.18M
Current deferred revenue - - - 0.00000M -
Net debt 2.33M 2.01M 2.09M 1.26M 0.37M
Short term debt 2.36M 2.02M 2.09M 1.60M 0.00270M
Short long term debt - - - - -
Short long term debt total 2.36M 2.02M 2.09M 1.60M 0.41M
Other stockholder equity 29.91M 29.47M 28.56M 27.32M 24.79M
Property plant equipment - - - - -
Total current assets 0.61M 0.05M 0.08M 0.46M 0.06M
Long term investments - - - - -
Net tangible assets - - - - -
Short term investments - - - - -
Net receivables 0.43M - - 0.00078M -
Long term debt - - - - -
Inventory 0.09M 0.00819M 0.00819M 0.00819M 0.02M
Accounts payable 0.62M 0.51M 0.41M 0.07M 0.18M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income 0.23M 0.00514M 0.68M 0.91M 0.19M
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - -0.00000M - 0.38M -
Deferred long term asset charges - - - - -
Non current assets total 0.35M 0.97M 0.97M 1.11M -
Capital lease obligations - - - - -
Long term debt total - - - - -
Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Investments - - - - -
Change to liabilities - - - - -
Total cashflows from investing activities - 0.00010M 0.01M -0.15459M 0.00945M
Net borrowings - - - - -
Total cash from financing activities 0.32M 0.07M 0.50M 1.37M 0.60M
Change to operating activities - - - - -
Net income -1.30748M -0.27417M -2.38417M -0.33678M -0.73695M
Change in cash 0.02M 0.00654M -0.33815M 0.30M 0.04M
Begin period cash flow 0.00666M 0.00011M 0.34M 0.04M -
End period cash flow 0.03M 0.00666M 0.00011M 0.34M 0.04M
Total cash from operating activities -0.29732M -0.05881M -0.84969M -0.91727M -0.57587M
Issuance of capital stock - - - - -
Depreciation - 0.00187M - 0.00063M -
Other cashflows from investing activities - -0.00001M - -0.10000M 0.00945M
Dividends paid - - - - -
Change to inventory -0.02696M - - 0.01M -0.02165M
Change to account receivables 0.23M - 0.00078M -0.00078M -
Sale purchase of stock - - - - -
Other cashflows from financing activities - 0.07M 0.50M 0.00000M 0.19M
Change to netincome - - - - -
Capital expenditures 0.00000M 0.00001M 0.00000M 0.00000M 0.00000M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital 0.17M 0.14M 0.38M -0.19830M 0.16M
Stock based compensation - - - - -
Other non cash items 0.84M 0.07M 1.16M -0.38282M -0.15900M
Free cash flow -0.29732M -0.05880M -0.84969M -0.91727M -0.57587M

Peer Comparison

Sector: Healthcare Industry: Medical Care Facilities

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
CYIO
CYIOS Corporation
- -% 0.0014 - - 0.39 1.52 1.76 -45.7365
HCA
HCA Healthcare, Inc.
9.93 2.63% 386.92 13.19 13.66 1.13 293.44 1.77 8.22
FSNUY
Fresenius SE & Co KGaA ADR
0.17 1.50% 11.47 16.87 9.44 0.42 0.78 0.79 5.37
JDHIY
JD Health International Inc
-0.15 3.30% 4.40 62.50 35.97 0.30 2.32 0.16 3.90
JDHIF
JD Health International Inc
- -% 5.85 57.75 32.68 0.29 2.11 0.16 3.90

Reports Covered

Stock Research & News

Profile

CYIOS Corporation operates as a holding company that engages in building, acquiring, and operating businesses across medical supplies, technology, and fintech industries. The company, through its subsidiary, delivers products to healthcare providers. CYIOS Corporation was founded in 1997 and is based in Deerfield Beach, Florida.

CYIOS Corporation

258 South Military Trail, Deerfield Beach, FL, United States, 33442

Key Executives

Name Title Year Born
Mr. David Lewis CEO & Director NA
Mr. Franco Devivo VP Marketing & Bus. Devel. NA
Mr. John Fredrick O'Shea CEO & Chairman of the Board 1968
Mr. Jonathan D. Leinwand Esq. Legal council 1970

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

We use cookies to help us improve, promote, and protect our services. By continuing to use this site, we assume you consent to our Cookies Policy. For more information, read our Privacy Policy and Terms and Conditions